K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 770.00
+7.00 (0.92%)
Oct 6, 2026, 3:30 PM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 8.87 billion as of October 5, 2026. Its market cap has increased by 14.23% in one year.
Market Cap
8.87B
Enterprise Value
8.14B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
770.00
ChartMarket Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 8.87B, a decrease of -18.99%. That is a compound annual growth rate of -6.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 8.95B | 16.85% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 10.66B |
| StemRIM | 10.28B |
| Carna Biosciences | 8.80B |
| Nano Holdings | 8.62B |
| OncoTherapy Science | 8.57B |
| CellSeed | 8.49B |
| Kidswell Bio | 8.20B |
| Chiome Bioscience | 8.05B |